Medical/Pharmaceuticals News & Press Release Distribution

Zymo Research Receives 510(k) Clearance for its Collection/Transport Device for COVID-19

IRVINE, Calif., March 11, 2021 /PRNewswire/ -- Zymo Research announced today the U.S. Food and Drug Administration (FDA) has cleared itsDNA/RNA Shield™ Collection Tube as a Class II medical device. The FDA's 510(k) clearance allows the product to be used as an In-vitro Diagnostic (IVD) device for...

2021-03-11 14:37 3255

Zymo Research Receives 510(k) Clearance for its Collection/Transport Device for COVID-19

Lianhua Qingwen -- The Leading TCM In Global Anti-Pandemic Programs

SHIJIAZHUANG, China, March 11, 2021 /PRNewswire/ -- As an epitome of the Chinese civilization, traditional Chinese medicine or TCM, and western medicine, reinforce each other to protect and improve people's health. Since the outbreak of the COVID-19 pandemic,China has been strengthening the inte...

2021-03-11 13:46 3604

Lianhua Qingwen -- The Leading TCM In Global Anti-Pandemic Programs

Baxter, a global leader in kidney care, reaffirms its commitment to equitable access to care on World Kidney Day

SINGAPORE, March 11, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today its support for World Kidney Day 2021 "Living Well with Kidney Disease". Kidney disease affects approximately 10% of the global population. Singapore currently ranks 4th wh...

2021-03-11 09:30 4348

Baxter, a global leader in Dialysis Care, reaffirms its commitment to equitable access to care on World Kidney Day

MANILA, Philippines, March 11, 2021 /PRNewswire/ -- Baxter, a global leader in dialysis care, is proud to support this year'sWorld Kidney Day , under the theme "Living Well with Kidney Disease". Kidney disease affects approximately 10% of the global populatio...

2021-03-11 09:30 2511

Baxter, a global leader in Dialysis Care, reaffirms its commitment to equitable access to care on World Kidney Day

BANGKOK, March 11, 2021 /PRNewswire/ -- Baxter, a global leader in dialysis care, is proud to support this year'sWorld Kidney Day , under the theme "Living Well with Kidney Disease". Kidney disease affects approximately 10% of the global population, and in T...

2021-03-11 09:30 2795

Baxter Announces New Data on Benefits of Remote Patient Management for Home Peritoneal Dialysis World Kidney Day 11 March 2021

* Published economic modelling shows estimated reduction in hospital episodes and potential financial savings from remote patient monitoring technology. * Baxter supports World Kidney Day Steering Committee in declaring 2021 the year of "Living Well with Kidney Disease". SINGAPORE, March 11, 2...

2021-03-11 09:30 3945

Baxter, a global partner of World Kidney Day welcomes new guidance issued by Vietnam Ministry of Health for End Stage Renal Disease (ESRD) Patients

HANOI, Vietnam, March 11, 2021 /PRNewswire/ -- Baxter, a global leader in dialysis care, is proud to support this year'sWorld Kidney Day , under the theme "Living Well with Kidney Disease". Kidney disease affects approximately 10% of the global population, and...

2021-03-11 09:30 2974

Baxter, a global leader in Dialysis Care, reaffirms its commitment to equitable access to care on World Kidney Day

JAKARTA, Indonesia, March 11, 2021 /PRNewswire/ -- Baxter, a global leader in dialysis care, is proud to support this year'sWorld Kidney Day , under the theme "Living Well with Kidney Disease". Kidney disease affects approximately 10% of the global population...

2021-03-11 09:30 3173

Ascentage Pharma to Present the Latest Results from Six Preclinical Studies at AACR Annual Meeting 2021

SUZHOU, China and ROCKVILLE, Md., March 11, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the latest preclinical...

2021-03-11 08:35 3620

First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic

BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-...

2021-03-11 08:00 1474

First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic

BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Ni...

2021-03-11 08:00 1421

Non-Invasive Liquid Biopsy to Help Cancer Diagnosis Gets CE Certification

LONDON, March 11, 2021 /PRNewswire/ -- Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformité Européenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management. TruBlood is a blood-based, non-invasi...

2021-03-11 07:00 3681

OPTEL Group on Track for Record Year in Asia-Pacific Pharma Sales

OPTEL, a world leader in pharmaceutical track and trace for more than 30 years, expects the current fiscal year to be its best in terms of sales and project delivery to the pharmaceutical industry since the inauguration of its manufacturing plant inGoa, India, in 2016. GOA VELHA, India, March 1...

2021-03-11 04:18 1682

Sofwave Receives Australian Regulatory Approval to Market SUPERB(TM), the Breakthrough Ultrasound Technology Treating Fine Lines & Wrinkles

It is time to position your aesthetic practice at the forefront of innovation! YOQNEAM, Israel, March 10, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received approval fromAustralia's The...

2021-03-10 23:40 2001

Sofwave Receives Australian Regulatory Approval to Market SUPERB™, the Breakthrough Ultrasound Technology Treating Fine Lines & Wrinkles

It is time to position your aesthetic practice at the forefront of innovation! YOQNEAM, Israel, March 10, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received approval fromAustralia's The...

2021-03-10 23:32 1573

Impact Therapeutics Announced First-Patient-Dose of Wee1 Inhibitor IMP7068 in the U.S.

SHANGHAI, March 10, 2021 /PRNewswire/ -- Impact Therapeutics announced today that the first patient was recently dosed in the first-in-human Phase 1 clinical study of Wee1 Inhibitor IMP7068 inthe United States. This is a Phase 1, open-label, multi-center, dose escalation and expansion study to e...

2021-03-10 21:14 1930

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders

SHANGHAI, March 10, 2021 /PRNewswire/ -- March 2nd-6th, 2021, Viva Biotech successfully hosted the 2021 Partnership Summit. Over 300 attendees joined the Summit, including representatives from global investment institutions, R&D heads from pharmaceutical companies, and business development leader...

2021-03-10 20:18 7504

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders

Sihuan Pharmaceutical (0460.HK): Be a friend of time, 2021 is the year of turning point

HONG KONG, March 10, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. plays a pivotal role in the domestic medical industry. It is a leading company inChina's CCV prescription drugs. According to IMS data in 2018, Sihuan Pharmaceutical is well-known on the national hospital prescrip...

2021-03-10 15:02 4103

Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization

SHANGHAI, March 9, 2021 /PRNewswire/ -- Arctic Vision, a China-based clinical-stage ophthalmology company focused on developing innovative therapies for pan-ocular diseases, today announced the completion of overUS$100 million Series B financing. The Series B round was led by Loyal Valley Capital...

2021-03-10 08:00 2379

Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization

Breaking the Cycle of Opioid Addiction: Alar Presents Positive Interim Results of Long-acting Buprenorphine Injectable (ALA-1000) in Opioid Dependent Patients

* ALA-1000 is the first, three-month slow-release Buprenorphine injection. * Initial results show a low initial burst without dose dumping effect, good safety, and tolerability. * ALA-1000 has the potential to significantly increase compliance and reduce the risk of relapse in patients treat...

2021-03-10 00:00 1806